Sabine Yerly

19.5k total citations
195 papers, 7.7k citations indexed

About

Sabine Yerly is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, Sabine Yerly has authored 195 papers receiving a total of 7.7k indexed citations (citations by other indexed papers that have themselves been cited), including 164 papers in Infectious Diseases, 138 papers in Virology and 44 papers in Epidemiology. Recurrent topics in Sabine Yerly's work include HIV Research and Treatment (137 papers), HIV/AIDS drug development and treatment (117 papers) and HIV/AIDS Research and Interventions (101 papers). Sabine Yerly is often cited by papers focused on HIV Research and Treatment (137 papers), HIV/AIDS drug development and treatment (117 papers) and HIV/AIDS Research and Interventions (101 papers). Sabine Yerly collaborates with scholars based in Switzerland, United States and France. Sabine Yerly's co-authors include Luc Perrin, Bernard Hirschel, Laurent Kaiser, Huldrych F. Günthard, Lionel Perrin, Viktor von Wyl, Thomas Klimkait, Philippe Bürgisser, Jürg Böni and Pietro Vernazza and has published in prestigious journals such as New England Journal of Medicine, The Lancet and The Journal of Experimental Medicine.

In The Last Decade

Sabine Yerly

187 papers receiving 7.5k citations

Peers

Sabine Yerly
Comparison fields: 5 of 147
  • Infectious Diseases 5.8k
  • Virology 5.0k
  • Epidemiology 2.1k
  • Immunology 587
  • Emergency Medicine 564
Rob Schuurman Netherlands
Keith Henry United States
Jeffrey Chodakewitz United States
Vincent Cálvez France
Kathleen Squires United States
Richard C. Reichman United States
Richard T. D’Aquila United States
Phyllis J. Kanki United States
Monique Nijhuis Netherlands
Françoise Brun‐Vézinet France
Rob Schuurman Netherlands View profile →
Citations per field, relative to Sabine Yerly
Sabine Yerly · 1×
Citations per year, relative to Sabine Yerly
Sabine Yerly · 1×

Countries citing papers authored by Sabine Yerly

Since Specialization
Citations

This map shows the geographic impact of Sabine Yerly's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sabine Yerly with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sabine Yerly more than expected).

Fields of papers citing papers by Sabine Yerly

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sabine Yerly. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sabine Yerly. The network helps show where Sabine Yerly may publish in the future.

Co-authorship network of co-authors of Sabine Yerly

This figure shows the co-authorship network connecting the top 25 collaborators of Sabine Yerly. A scholar is included among the top collaborators of Sabine Yerly based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sabine Yerly. Sabine Yerly is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Title Journal Authors Indexed citations
1 Rituximab‐to‐vaccine interval on SARS‐CoV‐2 immunogenicity in children: The potential role of prior natural infection Pediatric Allergy and Immunology Sabine Yerly, Paloma Parvex et al. 0
2 Hepatitis E Virus Infection Epidemiology in Recipients of Allogeneic Hematopoietic Cell Transplant Open Forum Infectious Diseases Johan Courjon, Sabine Yerly et al. 1
3 SARS-CoV-2 m-RNA Vaccine Response in Immunocompromised Patients: A Monocentric Study Comparing Cancer, People Living with HIV, Hematopoietic Stem Cell Transplant Patients and Lung Transplant Recipients Vaccines Natacha Bordry, Anne‐Claire Mamez et al. 1
4 Revisiting Cytomegalovirus Serology in Allogeneic Hematopoietic Cell Transplant Recipients Clinical Infectious Diseases Stavroula Masouridi‐Levrat, Léna Royston et al. 9
5 A Case of Mpox Reinfection Clinical Infectious Diseases Emmanuelle Boffi El Amari, Manuel Schibler et al. 27
6 Systematic screening of viral and human genetic variation identifies antiretroviral resistance and immune escape link eLife Huyen Nguyen, Christian Thorball et al. 4
7 Development and validation of the OUTCoV score to predict the risk of hospitalisation among patients with SARS-CoV-2 infection in ambulatory settings: a prospective cohort study BMJ Open Frédérique Jacquérioz, Stéphanie Baggio et al. 6
8 Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Viral Load in the Upper Respiratory Tract of Children and Adults With Early Acute Coronavirus Disease 2019 (COVID-19) Clinical Infectious Diseases Stéphanie Baggio, Arnaud G. L’Huillier et al. 73
9 Efficacy and safety of dolutegravir plus emtricitabine versus standard ART for the maintenance of HIV-1 suppression: 48-week results of the factorial, randomized, non-inferiority SIMPL’HIV trial PLoS Medicine Gilles Wandeler, Sabine Yerly et al. 20
10 Emergence of Acquired HIV-1 Drug Resistance Almost Stopped in Switzerland: A 15-Year Prospective Cohort Analysis Clinical Infectious Diseases Alexandra Scherrer, Viktor von Wyl et al. 39
11 Generation of a Recombinant Gag Virus-Like-Particle Panel for the Evaluation of p24 Antigen Detection by Diagnostic HIV Tests PLoS ONE Beatrice Vetter, Katrien Fransen et al. 12
12 HIV-1 Drug Resistance Transmission Networks in Southwest Switzerland AIDS Research and Human Retroviruses Erika Castro, Donatella Ciuffreda et al. 11
13 Epidemiological and Biological Evidence for a Compensatory Effect of Connection Domain Mutation N348I on M184V in HIV‐1 Reverse Transcriptase The Journal of Infectious Diseases Viktor von Wyl, Maryam Ehteshami et al. 23
14 Impact of newly HIV diagnosed individuals on the transmission of drug resistance Antiviral Therapy Sabine Yerly, Thomas Junier et al. 0
15 Drug resistance in newly HIV diagnosed individuals: transmission rate, clusters and persistence Antiviral Therapy Sabine Yerly, Thomas Junier et al. 2
16 Lower Respiratory Viral Illnesses American Journal of Respiratory and Critical Care Medicine Jorge Garbino, Margaret W. Gerbase et al. 110
17 Characterization of genotypic determinants in HR-1 and HR-2 gp41 domains in individuals with persistent HIV viraemia under T-20 AIDS Anne‐Geneviève Marcelin, Jacques Reynes et al. 29
18 Sampling lymphoid tissue cells by ultrasound-guided fine needle aspiration of lymph nodes in HIV-infected patients AIDS Pierre‐Alexandre Bart, Jean‐Yves Meuwly et al. 12
19 Switch to an unusual amino acid at codon 215 of the HIV-1 reverse transcriptase gene in seroconverters infected with zidovudine resistant variants. UCL Discovery (University College London) Sabine Yerly, Sabine Kinloch‐de Loes et al. 3
20 PREVALENCE DE LA TRANSMISSION DE VIRUS RESISTANT A LA ZIDOVUDINE EN SUISSE Schweizerische medizinische Wochenschrift Sabine Yerly, Sabine Kinloch-de-Loës et al. 9

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rob Schuurman Breakdown of academic impact, for papers by Keith Henry Breakdown of academic impact, for papers by Jeffrey Chodakewitz Breakdown of academic impact, for papers by Vincent Cálvez Breakdown of academic impact, for papers by Kathleen Squires Breakdown of academic impact, for papers by Richard C. Reichman Breakdown of academic impact, for papers by Richard T. D’Aquila Breakdown of academic impact, for papers by Phyllis J. Kanki Breakdown of academic impact, for papers by Monique Nijhuis Breakdown of academic impact, for papers by Françoise Brun‐Vézinet
Rankless by CCL
2026